IGF2BPs and EIF4A1, therefore, are oncogenic genes in ESCC and could serve as potential biomarkers and therapeutic targets for the diagnosis and treatment of ESCC. The gene discussed is EIF4A1; the disease is esophageal squamous cell carcinoma.